Latest SECTOR GAMMA AS Stock Portfolio
SECTOR GAMMA AS Performance:
2025 Q4: 10.48%YTD: 14.39%2024: -4.26%
Performance for 2025 Q4 is 10.48%, and YTD is 14.39%, and 2024 is -4.26%.
About SECTOR GAMMA AS and 13F Hedge Fund Stock Holdings
On 2026-02-12, the fund reported it's updated stock portfolio. In the 13F Holdings report, SECTOR GAMMA AS reported an equity portfolio of $438.7 Millions as of 31 Dec, 2025.
The top stock holdings of SECTOR GAMMA AS are BMY, MRK, MDT. The fund has invested 9.2% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 8.7% of portfolio in MERCK & CO INC.
The fund managers got completely rid off BAXTER INTL INC (BAX), VIATRIS INC (VTRS) and HUMANA INC (HUM) stocks. They significantly reduced their stock positions in PTC THERAPEUTICS INC (PTCT), ORGANON & CO (OGN) and ASCENDIS PHARMA A/S (ASND). SECTOR GAMMA AS opened new stock positions in REGENERON PHARMACEUTICALS (REGN), CRINETICS PHARMACEUTICALS IN (CRNX) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to ELEVANCE HEALTH INC FORMERLY (ANTX), AVANTOR INC (AVTR) and LANTHEUS HLDGS INC (LNTH).
The top stock holdings of SECTOR GAMMA AS are BMY, MRK, MDT. The fund has invested 9.2% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 8.7% of portfolio in MERCK & CO INC.
The fund managers got completely rid off BAXTER INTL INC (BAX), VIATRIS INC (VTRS) and HUMANA INC (HUM) stocks. They significantly reduced their stock positions in PTC THERAPEUTICS INC (PTCT), ORGANON & CO (OGN) and ASCENDIS PHARMA A/S (ASND). SECTOR GAMMA AS opened new stock positions in REGENERON PHARMACEUTICALS (REGN), CRINETICS PHARMACEUTICALS IN (CRNX) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to ELEVANCE HEALTH INC FORMERLY (ANTX), AVANTOR INC (AVTR) and LANTHEUS HLDGS INC (LNTH).
SECTOR GAMMA AS Annual Return Estimates Vs S&P 500
Our best estimate is that SECTOR GAMMA AS made a return of 10.48% in the last quarter. In trailing 12 months, it's portfolio return was 14.39%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| regeneron pharmaceuticals | 5,530,450 |
| crinetics pharmaceuticals in | 5,353,250 |
| cg oncology inc | 2,160,660 |
New stocks bought by SECTOR GAMMA AS
Additions
| Ticker | % Inc. |
|---|---|
| elevance health inc formerly | 238 |
| avantor inc | 45.76 |
| lantheus hldgs inc | 45.68 |
| edwards lifesciences corp | 32.09 |
| bristol-myers squibb co | 28.33 |
| becton dickinson & co | 21.64 |
| centene corp del | 21.06 |
| gilead sciences inc | 19.81 |
Additions to existing portfolio by SECTOR GAMMA AS
Reductions
| Ticker | % Reduced |
|---|---|
| ptc therapeutics inc | -47.57 |
| organon & co | -44.82 |
| ascendis pharma a/s | -32.98 |
| ionis pharmaceuticals inc | -31.73 |
| pfizer inc | -31.35 |
| medtronic plc | -11.14 |
| dexcom inc | -0.91 |
| hca healthcare inc | -0.91 |
SECTOR GAMMA AS reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| viatris inc | -6,621,620 |
| baxter intl inc | -8,687,920 |
| elanco animal health inc | -6,188,440 |
| solventum corp | -4,325,910 |
| arcellx inc | -2,627,940 |
| biontech se | -2,734,930 |
| icon plc | -4,369,220 |
| humana inc | -6,228,990 |
SECTOR GAMMA AS got rid off the above stocks
Sector Distribution
SECTOR GAMMA AS has about 93.2% of it's holdings in Healthcare sector.
- Healthcare
- Others
- Basic Materials
| Sector | % |
|---|---|
| Healthcare | 93.2 |
| Others | 5 |
| Basic Materials | 1.8 |
Market Cap. Distribution
SECTOR GAMMA AS has about 77.9% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- MID-CAP
- MEGA-CAP
- UNALLOCATED
- SMALL-CAP
- NANO-CAP
| Category | % |
|---|---|
| LARGE-CAP | 69.2 |
| MID-CAP | 9.9 |
| MEGA-CAP | 8.7 |
| UNALLOCATED | 5 |
| SMALL-CAP | 4.6 |
| NANO-CAP | 2.6 |
Stocks belong to which Index?
About 79.6% of the stocks held by SECTOR GAMMA AS either belong to S&P 500 or RUSSELL 2000 index.
- S&P 500
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| S&P 500 | 73.6 |
| Others | 20.4 |
| RUSSELL 2000 | 6 |
SECTOR GAMMA AS Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SECTOR GAMMA AS
SECTOR GAMMA AS has 36 stocks in it's portfolio. About 55.7% of the portfolio is in top 10 stocks. OGN proved to be the most loss making stock for the portfolio. MRK was the most profitable stock for SECTOR GAMMA AS last quarter.
Last Reported on: 12 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 4.55 | 60,956 | 19,951,500 | reduced | -0.81 | ||
| ANTX | elevance health inc formerly | 2.60 | 32,546 | 11,409,000 | added | 238 | ||
| ASND | ascendis pharma a/s | 0.79 | 16,305 | 3,476,880 | reduced | -32.98 | ||
| AVTR | avantor inc | 1.82 | 695,403 | 7,969,320 | added | 45.76 | ||
| BAX | baxter intl inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDX | becton dickinson & co | 5.86 | 132,376 | 25,690,200 | added | 21.64 | ||
| BIIB | biogen inc | 3.43 | 85,475 | 15,042,700 | added | 13.25 | ||
| BIO | bio rad labs inc | 1.64 | 23,750 | 7,196,010 | added | 4.04 | ||
| BMRN | biomarin pharmaceutical inc | 2.69 | 198,505 | 11,797,200 | added | 12.88 | ||
| BMY | bristol-myers squibb co | 9.17 | 745,955 | 40,236,800 | added | 28.33 | ||
| BNTX | biontech se | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BRKR | bruker corp | 2.73 | 254,697 | 11,998,800 | added | 1.51 | ||
| CAH | cardinal health inc | 2.90 | 61,946 | 12,729,900 | added | 4.05 | ||
| CERT | certara inc | 0.46 | 230,565 | 2,031,280 | unchanged | 0.00 | ||
| CNC | centene corp del | 2.42 | 258,109 | 10,621,200 | added | 21.06 | ||
| CRNX | crinetics pharmaceuticals in | 1.22 | 115,000 | 5,353,250 | new | |||
| CVS | cvs health corp | 3.21 | 177,599 | 14,094,300 | added | 13.7 | ||
| DXCM | dexcom inc | 1.15 | 76,122 | 5,052,220 | reduced | -0.91 | ||
| ELAN | elanco animal health inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||